The Gambia

in page functions
[French]
Total population (2014) 1,908,954
Birth cohort (2014) 81,149
Surviving Infants (surviving to 1 year per year, 2014) 76,761
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 49/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 73/1000
World Bank Index, IDA (2012) 3.35
Gross Nation Income (per capita US$, 2012) 510
Co-financing status (2013) Low-income
No. of districts/territories (2013) 6

Gavi support for Gambia

Type of support

Approvals

2001-2020 (US$)
(31 Jul 2014)

Commitments

2001-2020 (US$)
(31 Jul 2014)

Disbursements

2000-2014 (US$)
(31 Jul 2014)

% Disbursed

(31 Jul 2014)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Cash Support (CASHSUPP) $170,000 $195,000
Health system strengthening (HSS 1) $364,000 $738,500
HepB mono (NVS) $455,977 $455,977 $455,977 100%
Hib mono (NVS) $410,021 $410,021 $410,021 100%
HPV Demo (NVS) $192,500 $192,500 $102,038 53%
Immunisation services support (ISS) $671,640 $671,640 $545,300 81%
Injection safety support (INS) $101,184 $101,184 $101,184 100%
IPV (NVS) $166,000 $358,000
Measles (NVS) $96,195 $163,195 $90,535 94%
Meningitis A - campaign (NVS) $792,500 $792,500 $788,739 100%
Meningitis A - operational costs (OPC) $727,500 $727,500 $727,500 100%
Penta (NVS) $3,640,170 $4,141,170 $3,645,836 100%
Pneumo (NVS) $5,717,392 $7,025,392 $5,899,048 103%
Rotavirus (NVS) $1,789,500 $3,526,500 $1,423,550 80%
Tetra DTP-Hib (NVS) $3,675,683 $3,675,683 $3,675,683 100%
Vaccine Introduction Grant (VIG) $1,006,250 $1,006,250 $806,250 80%
Total $19,976,512 $24,181,012 $18,671,662

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Gambia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2013)

Grade of confidence


N/A
DTP3 - Official country estimates (2013) 98%
M:F sex ratio at birth (2014) 1.03
Household survey: DTP3 coverage for male (2013) 89.10%
Household survey: DTP3 coverage for female (2013) 86.20%
Household survey: Last DTP3 survey (2013) 88%
% districts achieving > 80% DTP3 coverage (2013) 100%
% districts achieving < 50% DTP3 coverage (2013) 0%
MCV WHO/UNICEF estimates (2013) 96%
Polio WHO/UNICEF estimates (2013) 96%

Breakdown of support

Non-vaccine support Vaccine support
12% 88%
$2,180,233 $16,491,426

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Gambia

18 September 2014

Nepal IPV

Nepal becomes first country to introduce IPV with Gavi support

Nepal is one of 25 countries who have received approval to begin using IPV with Gavi support. Afghanistan and Pakistan are also planning to introduce IPV by end of next year.

04 February 2014

HPV vaccine with GAVI support

206,000 more girls to benefit from HPV vaccine with GAVI Alliance support

10 countries approved in latest round of HPV vaccine demonstration programmes.

08 October 2013

Mosquito

GAVI statement on latest trial data on malaria vaccine candidate RTS,S

Latest data published by Glaxosmithkline and PATH Malaria Vaccine Initiative

close icon

modal window here